numares AG Revenue and Competitors

Regensburg,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • numares AG's estimated annual revenue is currently $14.8M per year.(i)
  • numares AG's estimated revenue per employee is $251,000

Employee Data

  • numares AG has 59 Employees.(i)
  • numares AG grew their employee count by -5% last year.

numares AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is numares AG?

numares is a fast-growing innovative diagnostics company that develops and markets software-based test systems for high throughput use in clinical diagnostics and life science research. The AXINON® System and its individual diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a “numaric” spectrum to evaluate metabolic networks. The output from these analyses provides physicians valuable information on the disease status of patients. numares developed its proprietary Magnetic Group Signaling (MGS®) technology to enable NMR for highly standardized and rapid throughput testing, forming a cost-effective new solution for real-time diagnostic purposes. The metabolic tests have the potential to address unmet medical needs in various field such as cardiovascular diseases, nephrology, oncology and neurology, shaping an important pillar in precision medicine. More information can be found at www.numares.com. For further information please contact: numares AG Dipl.-Biol. Christiane Proll, MBA Tel.: +49 941 2809 49-14 E-Mail: christiane.proll@numares.com

keywords:N/A

N/A

Total Funding

59

Number of Employees

$14.8M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M8315%N/A
#2
$15.4M10622%N/A
#3
$15.4M10622%N/A
#4
$48.2M19939%N/A
#5
$68.7M25510%N/A